Lung/Thoracic Tumours
The links below provide further information on each researcher and their work.
| Dr David Baldwin |
Clinical lung cancer; epidemiology; diagnosis |
| Dr Tracey Bradshaw |
Cancer therapeutics; chemoprevention; toxicology |
| Prof John Britton |
Tobacco control studies; lung cancer; gastrointestinal cancer; bladder cancer |
| Dr Caroline Chapman |
Immune biomarkers; lung cancer; breast cancer; B cells |
| Prof Karen Cox |
Cancer care; palliative care; clinical trials management; patient experiences; follow-up; survivorship; end of life care |
| Dr Amir Ghaemmaghami |
Immunology; tissue engineering; lung tissue |
| Dr Anna Grabowska |
Pre-clinical cancer modelling/imaging; target validation; tumour
microenvironment |
| Prof Ian Hall |
Respiratory medicine; genetics of airway diseases |
| Prof Richard Hubbard |
Aetiology and health care; lung cancer; national lung audit |
| Prof Alan Knox |
Molecular pathogenesis; COPD; lung disease |
| Dr Rajendra Kumari |
Pre-clinical cancer modelling; bioimaging; tumour microenvironment; targeted therapies |
| Dr Paul Maddison |
Paraneoplastic disorders; small cell lung cancer |
|
Dr Luisa Martinez-Pomares
|
T-Regs; macrophages; mannose receptor; lung epithelium |
| Prof John Robertson |
Immune biomarkers; early detection; lung and breast tumours |
| Dr Laila Tata |
Lung cancer (national audit) |
| Dr Andrew Wilcock |
Supportive care; palliative care; cachexia; rehabilitation |
| Dr Sebastiaan Winkler |
Post-transcriptional gene regulation; deadenylase enzymes; deadenylase inhibitors; Ccr4-Not; BTG/Tob proteins; leukaemia and lymphoma; breast cancer |